Background We aimed to describe neuroimaging features, clinical profiles and long-term outcomes in patients with iatrogenic cerebral amyloid angiopathy (iCAA). Methods We performed a systematic ...

Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA ...

Utilizing amyloid imaging, we aimed to find the difference in amyloid deposition between patients ... assessment were listed in Table 1. Initial blood chemistry and cerebral spinal fluid (CSF) ...

Background: Cerebral amyloid angiopathy (CAA), in which amyloid-β (Aβ) is deposited in cerebral and meningeal blood vessels, is associated with not only stroke but also cognitive dysfunction. CAA is ...

The hunt for blood-based biomarkers is continuing apace. At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and blood, conference ...

Background: Cerebral amyloid angiopathy (CAA) is a hemorrhagic cerebrovascular disease that is thought to be due to excess protein deposition in vessel walls that lead to fragility and increase the ...

Cerebral spinal fluid examination revealed ... No neurofibrillary tangles or amyloid plaques were found in the parenchyma. Reactive gliosis, strong upregulation of microglia and multiple ...

How scary is that, when you start treating 50-year-olds with something that causes cerebral bleeding?” Selkoe said amyloid skeptics don’t understand the science. “They don’t feel it the ...

Once breakthroughs in brain imaging accurately quantified amyloid plaques and tau tangles, they could finally prove that experimental agents actually removed amyloid and lowered tau. And contrary ...

All patients with cerebral MR imaging (cMRI) of sufficient diagnostic quality were included. cMRIs were retrospectively analyzed according to immunotherapy response assessment for neuro-oncology ...